Gastroenterology Studies

Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer's and Parkinson's diseases as druggable targets through Withania somnifera bioactives: an in silico study.

The gut microbiota's dysbiosis may lead to neurodegenerative diseases like Alzheimer's and Parkinson's due to increased gut and blood-brain barrier permeability. () is a promising plant for treating neurodegenerative diseases and bowel disorders. The researchers identified five proteins and five best lead compounds after molecular docking analysis and simulation studies, revealing HTR1A and HTR7 proteins with the leads Withanolide E and Withanolide A against them, respectively as the most effective targets. Thus by targeting common potential targets, modulation with bioactive compounds present in can result in effective control of these diseases.

Shukla R et al (2023).
J Biomol Struct Dyn.
PubMed:
35491707